DERIVE POLYCYCLIQUE DE CINNAMIDE
«Composition pharmaceutique nouvelle» Il est révélé des compositions pharmaceutiques nouvelles contenant de l'acide 3'-[(2Z)-[1-(3,4-diméthylphényl)-1,5-dihydro-3-méthyl-5-oxo-4H-pyrazole-4-ylidène]hydrazino]-2'-hydroxy-[1,1'-biphényl]-3-carboxylique bis-(monoéthanolamine) (eltro...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | French |
Published |
02.03.2009
|
Edition | 7 |
Online Access | Get full text |
Cover
Loading…
Summary: | «Composition pharmaceutique nouvelle» Il est révélé des compositions pharmaceutiques nouvelles contenant de l'acide 3'-[(2Z)-[1-(3,4-diméthylphényl)-1,5-dihydro-3-méthyl-5-oxo-4H-pyrazole-4-ylidène]hydrazino]-2'-hydroxy-[1,1'-biphényl]-3-carboxylique bis-(monoéthanolamine) (eltrombopag olamine) et des procédés pour leur préparation.
Disclosed is a compound represented by the formula (I):
or a pharmacologically acceptable salt thereof, wherein Ar 1 represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like, Ar 2 represents a phenyl group which may be substituted by a C1-6 alkoxy group, or the like, X 1 represents a double bond or the like, and Het represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like. The compound or the salt is effective as a therapeutic or prophylactic agent for a disease associated with A². |
---|---|
Bibliography: | Application Number: MA20080031220 |